Driehaus Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Driehaus Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,359	Closed	-$365K	–	693
2015 Q3	$365K	Buy	+18,359	New	+$421K	0.01%	459
2015 Q2	–	Sell	-247,000	Closed	-$3.84M	–	637
2015 Q1	$3.84M	Buy	247,000 +229,900	+1,344%	+$3.56M	0.13%	192
2014 Q4	$244K	Buy	+17,100	New	+$181K	0.01%	458

Other funds holding SCMP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Driehaus Capital Management's SCMP Position: Q4 2015 in Review

Driehaus Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2015, closing a stake of 18,359 shares — an estimated $365K sold.

Driehaus Capital Management first reported a position in SCMP in Q4 2014 and held it in 3 quarters. The position peaked at $3.84M in Q1 2015. 149 funds tracked by Wall St. Rank hold SCMP as of Q4 2015.

Driehaus Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Driehaus Capital Management sold 18,359 Sucampo Pharmaceuticals, Inc. shares in Q4 2015, an estimated $365K.
Driehaus Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 3 quarters.
Driehaus Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $3.84M in Q1 2015.
149 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2015.

Based on Driehaus Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.